(Q87609752)

English

Bezafibrate, a peroxisome proliferator-activated receptor α agonist, decreases circulating CD14(+)CD16(+) monocytes in patients with type 2 diabetes

scientific article published on 30 July 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25134759%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Bezafibrate, a peroxisome proliferator-activated receptor α agonist, decreases circulating CD14(+)CD16(+) monocytes in patients with type 2 diabetes (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25134759%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

type 2 diabetes

1 reference

based on heuristic

inferred from title

author name string

Tomoko Terasawa

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25134759%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Yoshimasa Aso

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25134759%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Kyoko Omori

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25134759%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Maiko Fukushima

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25134759%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Atsushi Momobayashi

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25134759%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Toshihiko Inukai

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25134759%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

publication date

30 July 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25134759%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Translational Research

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25134759%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

165

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25134759%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25134759%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

336-345

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25134759%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Monocyte and macrophage dynamics during atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.07.008

7 January 2021

The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.07.008

7 January 2021

Blood monocytes consist of two principal subsets with distinct migratory properties

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.07.008

7 January 2021

Strong depletion of CD14(+)CD16(+) monocytes during haemodialysis treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.07.008

7 January 2021

CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-alpha levels

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.07.008

7 January 2021

Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.07.008

7 January 2021

Modulation of hepatic inflammatory risk markers of cardiovascular diseases by PPAR-alpha activators: clinical and experimental evidence

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.07.008

7 January 2021

PPARalpha agonists suppress osteopontin expression in macrophages and decrease plasma levels in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.07.008

7 January 2021

Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.07.008

7 January 2021

Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.07.008

7 January 2021

CD14++CD16+ monocytes and cardiovascular outcome in patients with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.07.008

7 January 2021

CD14dimCD16+ and CD14+CD16+ monocytes in obesity and during weight loss: relationships with fat mass and subclinical atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.07.008

7 January 2021

Exercise training-induced lowering of inflammatory (CD14+CD16+) monocytes: a role in the anti-inflammatory influence of exercise?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.07.008

7 January 2021

CD14+CD16++ cells derived in vitro from peripheral blood monocytes exhibit phenotypic and functional dendritic cell-like characteristics

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.07.008

7 January 2021

Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.07.008

7 January 2021

PPARalpha ligands inhibit radiation-induced microglial inflammatory responses by negatively regulating NF-kappaB and AP-1 pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.07.008

7 January 2021

Identifiers

10.1016/J.TRSL.2014.07.008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25134759%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25134759%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q87609752&oldid=1745000632"